Under development products, are being investigated for the delivery of both liquid and solid formulations of vaccines

Of late, there has been an evident shift in interest to non-invasive immunization methods, which include oral, intranasal and transdermal modes of administration. Currently, many biopharmaceutical companies and clinical research institutes are engaged in the development of novel vaccine delivery systems, taking into consideration the specific requirements of large scale immunization initiatives. As a result, significant efforts have been put into the development of drug delivery technologies / devices, such as microneedle patches, electroporation-based needle free injection systems, jet injectors, inhalation-based delivery systems, biodegradable implants and certain novel types of oral delivery systems. It is worth highlighting that most of the aforementioned systems are specifically being designed to facilitate pain-free administration of vaccines and allow self-administration.

 

Key Inclusions

• A detailed assessment of the overall novel vaccine delivery devices market landscape, featuring an elaborate list of device developers and analysis based on a number of relevant parameters, such as year of establishment, company size, geographical location, type of device (autoinjectors, microneedle patches, jet injectors, dry powder inhalers, microinjectors, nasal delivery systems, pen injectors, biodegradable implants, electroporation-based needle free injection systems and novel oral delivery systems), route of administration (subcutaneous, transdermal, intramuscular, intradermal, inhalation, intranasal, and oral), drug delivery mechanism (mechanical, electrical and miscellaneous), nature of vaccine administration (invasive and non-invasive), speed of administration (fast, moderate and slow), self- administration potential, provisions for audio / visual feedback, device usability (disposable and reusable), type of needle (needleless, fixed needle, detachable needle, and hidden needle), and current development status of novel vaccine delivery systems (preclinical / discovery, clinical and marketed).
• A detailed competitiveness analysis of novel vaccine delivery devices, taking into consideration the supplier power (based on the year of establishment of developer company) and key product specifications (such as route of administration, device usability, drug delivery mechanism, availability of needle safety system, speed of administration, self-administration potential, provisions for audio / visual feedback, nature of administration, cold chain requirement and current status of development).
• An analysis evaluating the effectiveness of various vaccines delivery devices in order to compare their respective strengths and capabilities based on a variety of relevant parameters, such as type of active ingredient, dosage form, route of administration, target disease indication and target patient population.
• A detailed list of marketed and pipeline vaccine candidates that are anticipated to be developed in combination with novel vaccine delivery devices in the near future, featuring analysis based on parameters, such as type of active ingredient, dosage form, route of administration, target disease indication and target patient population.

 

To order this 500+ page report, which features 90+ figures and 160+ tables, please visit this - https://www.rootsanalysis.com/reports/view_document/vaccine-delivery-devices/280.html

 

The USD 1.5 billion (by 2030) financial opportunity within the novel vaccine delivery devices market has been analyzed across the following segments:

• Type of device
• Electroporation-based needle free injection system
• Oral delivery systems
• Nasal delivery systems
• Jet injectors
• Microneedle patches
• Microinjectors

 

• Route of administration

• Oral
• Intramuscular
• Intranasal
• Intradermal
• Subcutaneous

 

• Type of vaccine

• Bivalent Oral Polio Vaccine
• BCG Vaccine
• DTP-HepB-Hib Vaccine
• Pneumococcal Conjugate Vaccine
• Influenza Vaccine
• Measles Vaccine
• Tetanus-Diphtheria Vaccine
• Others

 

• Key geographical regions
• North America
• Europe
• Asia Pacific
• Rest of the world

 

The Novel Vaccine Delivery Devices Market, 2019-2030 report features the following companies, which we identified to be key players in this domain:  

• 3M
• Becton Dickinson
• Consort Medical
• D’Antonio Consultants International
• Enesi Pharma
• Ichor Medical
• Iconovo
• Inovio Pharmaceuticals
• PharmaJet
• Union Medico

 

Table of Contents

 

1. PREFACE
 

2. EXECUTIVE SUMMARY

 

3. INTRODUCTION

 

4. MARKET LANDSCAPE

 

5. DEVICE COMPETITIVENESS ANALYSIS
 

6. TECHNOLOGY EFFECTIVENESS ANALYSIS
 

7. NOVEL VACCINE DELIVERY DEVICES: LIKELY VACCINE CANDIDATES
 

8. COMPANY PROFILES
 

9. PARTNERSHIPS AND COLLABORATIONS

 

10. SWOT ANALYSIS

 

11. MARKET SIZING AND OPPORTUNITY ANALYSIS

 

12. EXECUTIVE INSIGHTS
 

13. CONCLUDING REMARKS
 

14. APPENDIX I: TABULATED DATA

 

To purchase a copy, please visit https://www.rootsanalysis.com/reports/view_document/vaccine-delivery-devices/280.html or email [email protected]

 

Contact Details

Gaurav Chaudhary

+1 (415) 800 3415

[email protected]